Examination of Bromocriptine on Homeostatic and Hedonic Mechanisms of Food Intake in Individuals at High Risk for T2DM

NCT05405244 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

55

Enrollment

OTHER

Sponsor class

Conditions

Overweight and Obesity
Eating Behavior

Interventions

DRUG: Placebo
DRUG: Bromocriptine-QR

Sponsor

University of North Carolina, Chapel Hill

Collaborators

[object Object]